Comparison of clinical and metabolic effects of pasireotide and pituitary surgery in Cushing disease

Risultato della ricerca: Other


Pituitary surgery represents the first-line treatment for most patients with Cushing’s disease (CD). In the case of surgery failure, additional treatment options are required. Pasireotide has shown favourable results in the first-line treatment of patients with CD, who are not candidates for surgery or in the second-line when surgery has failed. The aim of the current study is to compare the effects of surgery and pasireotide treatment in a cohort of patients with CD, and to evaluate the differences in response rate in terms of hormonal and clinical control, and improvement of metabolic complications.
Lingua originaleEnglish
Numero di pagine1
Stato di pubblicazionePublished - 2017


Cita questo